Level C· Early human research exploring benefitsCase Report / SeriesEurope PMCOpen access

Autologous Millifat Grafting as a Reconstructive Strategy for Complex Lower Limb Defects in a Diabetic Patient After Necrotizing Fasciitis

Rodríguez Franco K., Alviar Rueda JD., Vega Corredor MC., Castillo Hernandez C.

Case Report / Series on Type 2 Diabetes, published in Cureus (2026) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
Cureus (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41669606
PMCID
PMC12885584
DOI
10.7759/cureus.101252

Abstract (original English)

Lower limb ulcers, especially in patients with diabetes mellitus, represent a major therapeutic challenge, particularly when complicated by severe infections such as necrotizing fasciitis. These conditions often require extensive surgical interventions, including amputation. We present the case of a 68-year-old female patient with poorly controlled type 2 diabetes mellitus who developed extensive necrotizing fasciitis in the left lower limb following trauma with plant material, resulting in a large soft tissue defect. The patient was not a candidate for regional or distant flaps due to her non-revascularizable micro- and macroangiopathic disease. A prior CT angiography showed complete occlusion of the anterior and posterior tibial arteries, evaluated by Orthopedics, who indicated amputation of the limb. Due to the patient's refusal to undergo amputation, autologous millifat grafts were selected for the salvage treatment strategy. This case highlights the potential of this technique as a limb salvage tool, demonstrating its effectiveness in complex clinical scenarios by promoting tissue regeneration and avoiding major ablative procedures.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research